LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study
2020
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
68
Citations
NaN
KQI